Natco to recall nanotech anticancer in India
21 July 2009
Anju Ghangurde
The drugs controller general of India (
DCGI) has ordered a recall of
Natco Pharma's breast cancer drug, Albupax (paclitaxel in an albumin bound nano-particle form) over concerns that the product may cause liver damage.
Albupax is a cut-price generic version of Abraxis BioScience's Abraxane,...
Please Login to read the full article.
21 July 2009
Anju Ghangurde
Albupax is a cut-price generic version of Abraxis BioScience's Abraxane,...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
